Cutler Group’s MediciNova MNOV Stock Holding History

Cutler Group’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,800	Closed	-$3K	–	6096
2021 Q1	$3K	Buy	+2,800	New	+$16.3K	﹤0.01%	4720
2018 Q2	–	Sell	-800	Closed	-$2K	–	4610
2018 Q1	$2K	Buy	+800	New	+$7.97K	﹤0.01%	3779

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cutler Group's MNOV Position: Q1 2024 in Review

Cutler Group sold out of MediciNova (MNOV) in Q1 2024, closing a stake of 2,000 shares — an estimated $3K sold.

Cutler Group first reported a position in MNOV in Q2 2016 and held it in 17 quarters. The position peaked at $39K in Q1 2021. 35 funds tracked by Wall St. Rank hold MNOV as of Q1 2024.

Cutler Group reported no remaining MediciNova position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 2,000 MediciNova shares in Q1 2024, an estimated $3K.
Cutler Group first reported a position in MediciNova in Q2 2016 and held it in 17 quarters.
Cutler Group's MediciNova position peaked at $39K in Q1 2021.
35 funds tracked by Wall St. Rank held MediciNova as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.